Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Amortizatization of Intangibles (2020 - 2025)

Bolt Biotherapeutics' Amortizatization of Intangibles history spans 6 years, with the latest figure at $636000.0 for Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles rose 31.68% year-over-year to $636000.0; the TTM value through Sep 2025 reached $2.2 million, up 11.38%, while the annual FY2024 figure was $2.6 million, 11.42% down from the prior year.
  • Amortizatization of Intangibles for Q3 2025 was $636000.0 at Bolt Biotherapeutics, up from $624000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.9 million in Q4 2022 and bottomed at -$2.5 million in Q3 2022.
  • The 5-year median for Amortizatization of Intangibles is $636000.0 (2025), against an average of $691894.7.
  • The largest YoY upside for Amortizatization of Intangibles was 613.24% in 2022 against a maximum downside of 184.62% in 2022.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $544000.0 in 2021, then skyrocketed by 613.24% to $3.9 million in 2022, then tumbled by 108.94% to -$347000.0 in 2023, then soared by 188.76% to $308000.0 in 2024, then soared by 106.49% to $636000.0 in 2025.
  • Per Business Quant, the three most recent readings for BOLT's Amortizatization of Intangibles are $636000.0 (Q3 2025), $624000.0 (Q2 2025), and $615000.0 (Q1 2025).